Genmab reported DKK422M in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -82.79M 8.09M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Amarin AMRN:US $ 8.87M 9.87M
Argen X Bv ARGX:BB 105.25M 129.53M
Bayer BAYN:GR € 1537M 1825M
Bluebird Bio BLUE:US $ -231.42M 25.67M
Exelixis EXEL:US $ 124.89M 126.9M
Fresenius Medical Care FME:GR € 355.01M 42.99M
Genmab GEN:DC DK 422M 1002M
GlaxoSmithKline GSK:LN 1482M 225M
GN Store Nord GN:DC DK 552M 60M
H. Lundbeck A/S LUN:DC 484M 313M
Immunogen IMGN:US $ -30.74M 3.31M
Insmed INSM:US $ -116699000 25.3M
Merck MRK:GR € 1265.8M 32M
Novartis NOVN:VX SF 4424M 620M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Sanofi SAN:FP € 2180M 376M
William Demant Holding WDH:DC 1.54B 226M